Robinson P J, Sly P D
Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.
Arch Dis Child. 1990 Mar;65(3):311-2. doi: 10.1136/adc.65.3.311.
Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.
对7名正在服用高剂量胰酶补充剂的囊性纤维化患者进行了评估,以确定达到足够的脂肪吸收是否需要这一剂量。患者将摄入量从平均每天45粒胶囊减至21粒。5名患者在服用减少后的酶剂量时脂肪吸收不良没有任何显著变化。